Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia

Leukemia

Volumn 11, Issue 7, 1997, Pages 1078-1085

  Den Boer, M L ^a   Zwaan, C M ^a   Pieters, R ^a   Kazemier, K M ^a   Rottier, M M A ^a   Flens, M J ^a   Scheper, R J ^a   Veerman, A J P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Childhood acute lymphoblastic leukemia; Flow cytometry; Immunocytochemistry; LRP; MRP; P glycoprotein

Indexed keywords

ACETONE; ANTIBODY; FORMALDEHYDE; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; METHANOL; PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; COMPARATIVE STUDY; CRYOPRESERVATION; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; METHODOLOGY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TISSUE FIXATION;

EID: 0030788969     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400729     Document Type: Article

References (24)

1. Kartner N, Shales M, Riordan JR, Ling V. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res 1983; 43: 4413-4419.
2. Cole SPC, Bhardwaj C, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650-1654.
3. Krishnamachary N, Center MS. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 1993; 53: 3658-3661.
4. Scheper RJ, Broxterman HJ, Scheffer CL, Kaaijk P, Dalton WS, Van Heijningen THM, Van Kalken CK, Slovak ML, De Vries EGE, Van der Valk P, Meijer CJLM, Pinedo HM. Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993; 53: 1475-1479.
5. Beck J, Handgretinger R, Dopfer R, Klingebiel T, Niethammer D, Gekeler V. Expression of mdr1, mrp, topoisomerase IIα/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. Br J Haematol 1995; 89: 356-363.
6. Goasguen JE, Dossot JM, Fardel O, Le Mee F, Le Gall E, Leblay R, LePrise PY, Chapereon J, Fauchet R. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood 1993; 81: 2394-2398.
7. Kingreen D, Sperling C, Notter M, Schmidt C, Diddens H, Riehm H, Thiel E, Ludwig WD. Sequential analysis of P-glycoprotein expression in childhood acute lymphoblastic leukemia. Hematol Blood Transf 1992; 34: 23-28.
8. Rothenberg ML, Mickley LA, Cole DE, Balis FM, Tsuruo T, Poplack DC, Fojo AT. Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood 1989; 74: 1388-1395.
9. Pieters R, Hongo T, Loonen AH, Huismans DR, Broxterman HJ, Hählen K, Veerman AJP. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia. Br J Cancer 1992; 65: 691-697.
10. Sauerbrey A, Zintl F, Volm M. P-glycoprotein and glutathione S-transferase π in childhood acute lymphoblastic leukaemia. Br J Cancer 1994; 70: 1144-1149.
11. Den Boer ML, Pieters R, Kazemier KM, Rottier MMA, Scheper RJ, Flens MJ, Janka G, Veerman AJP. LRP but not P-gp or MRP may cause drug resistance in childhood ALL. Proc Am Ass Cancer Res 1996; 37: 319-320.
12. Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HSL, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Warnke R, Weinstein R. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 1996; 56: 3010-3020.
13. Hamada H, Tsuruo T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 1986; 83: 7785-7789.
14. Arceci RJ, Stieglitz K, Bras J, Schinkel A, Baas F, Croop J. Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Res 1993; 53: 310-317.
15. Feller N, Kuiper CM, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Br J Cancer 1995; 72: 543-549.
16. Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJLM, Scheper RJ, Zaman GJR. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res 1994; 54: 4557-4563.
17. Bakos E, Hegedüs T, Holló Z, Welker E, Tusnády GE, Zaman GJR, Flens MJ, Váradi A, Sarkadi B. Membrane topology and glycosylation of the human multidrug resistance-associated protein. J Biol Chem 1996; 271: 12322-12326.
18. Tiirikainen MI, Elonen E, Ruutu T, Jansson SE, Krusius T. Clinical significance of P-glycoprotein expression in acute leukaemia as analysed by immunocytochemistry. Eur J Haematol 1993; 50: 279-285.
19. Wattel E, Lepelley P, Merlat A, Sartiaux C, Bauters F, Jouet JP, Fenaux P. Expression of the multidrug resistance P glycoprotein in newly diagnosed adult lymphoblastic leukemia: absence of correlation with response to treatment. Leukemia 1995; 9: 1870-1874.
20. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Treille D, Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473-476.
21. + acute myeloblastic leukemia/acute lymphoblastic leukemia. Blood 1993; 82: 3445-3451.
22. Tafuri A, Sommaggio A, Burba L, Albergoni MP, Petrucci MT, Mascolo MG, Testi AM, Basso G. Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia. Leukemia Res 1995; 19: 927-931.
23. Brophy NA, Marie JP, Rojas VA, Warnke RA, McFall PJ, Smith SD, Sikic BI. Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques. Leukemia 1994; 8: 327-335.
24. Zhou DC, Marie JP, Suberville AM, Zittoun R. Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods. Leukemia 1992; 6: 879-885.